Ambuja Cements Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
AMBUJACEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ambuja Cements has confirmed to the exchanges that there is no deviation or variation in the use of proceeds from its preferential issue of equity shares (on conversion of warrants) for the quarter ended 30 June 2025. The company had raised Rs 15,000.046 crore in two tranches in March-April 2024 for capital expenditure, de-bottlenecking, logistics, digital initiatives, ESG compliance, acquisitions, working capital, technology, and general corporate purposes. Of this, Rs 14,385.1 crore (about 95.9%) has been utilised as of 30 June 2025, broadly in line with the stated objects. The Audit Committee reviewed and approved the statement at its meeting on 31 July 2025, with no comments from auditors either. This is a routine SEBI compliance filing under Reg. 32 confirming disciplined deployment of the fundraise.
No negative impact for shareholders — the filing confirms that the large Rs 15,000 crore fundraise is being deployed as promised with no misuse or change in stated purpose. The nearly full utilisation suggests capex and growth plans are progressing on track, which is a mildly positive signal for execution visibility.